These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26758865)

  • 1. Adherence to Sublingual Immunotherapy.
    Incorvaia C; Mauro M; Leo G; Ridolo E
    Curr Allergy Asthma Rep; 2016 Feb; 16(2):12. PubMed ID: 26758865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the compliance to a short schedule of subcutaneous immunotherapy and to sublingual immunotherapy during three years of treatment.
    Manzotti G; Riario-Sforza GG; Dimatteo M; Scolari C; Makri E; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2016 Nov; 48(6):224-227. PubMed ID: 27852426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
    Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
    J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
    Manzotti G; Pappacoda A; Dimatteo M; Scolari C; Riario-Sforza GG; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):138-43. PubMed ID: 24067339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compliance with allergen immunotherapy and factors affecting compliance among patients with respiratory allergies.
    Musa F; Al-Ahmad M; Arifhodzic N; Al-Herz W
    Hum Vaccin Immunother; 2017 Mar; 13(3):514-517. PubMed ID: 27820664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in allergen immunotherapy as a treatment of asthma.
    Incorvaia C; Makri E; Ridolo E; Pellicelli I; Panella L
    Expert Rev Respir Med; 2019 Dec; 13(12):1161-1167. PubMed ID: 31581868
    [No Abstract]   [Full Text] [Related]  

  • 8. 30 years of sublingual immunotherapy.
    Passalacqua G; Bagnasco D; Canonica GW
    Allergy; 2020 May; 75(5):1107-1120. PubMed ID: 31715001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of patients for sublingual versus subcutaneous immunotherapy.
    Larenas Linnemann DE; Blaiss MS
    Immunotherapy; 2014; 6(7):871-84. PubMed ID: 25290418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy compliance: comparison of subcutaneous versus sublingual immunotherapy.
    Leader BA; Rotella M; Stillman L; DelGaudio JM; Patel ZM; Wise SK
    Int Forum Allergy Rhinol; 2016 May; 6(5):460-4. PubMed ID: 26718480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution of allergen immunotherapy from empirical desensitization to immunological treatment.
    Incorvaia C; Dell'albani I; Di Cara G; Piras P; Frati F
    Eur Ann Allergy Clin Immunol; 2013 Oct; 45 Suppl 2():5-10. PubMed ID: 24129082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more.
    Marogna M; Spadolini I; Massolo A; Canonica GW; Passalacqua G
    Allergy; 2004 Nov; 59(11):1205-10. PubMed ID: 15461603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to allergen immunotherapy improves when patients choose the route of administration: Subcutaneous or sublingual.
    Sánchez J
    Allergol Immunopathol (Madr); 2015; 43(5):436-41. PubMed ID: 25201758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report.
    Pajno GB; Bernardini R; Peroni D; Arasi S; Martelli A; Landi M; Passalacqua G; Muraro A; La Grutta S; Fiocchi A; Indinnimeo L; Caffarelli C; Calamelli E; Comberiati P; Duse M;
    Ital J Pediatr; 2017 Jan; 43(1):13. PubMed ID: 28257631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated with Adherence to Allergen Specific Subcutaneous Immunotherapy.
    Lee JH; Lee SH; Ban GY; Ye YM; Nahm DH; Park HS; Shin YS
    Yonsei Med J; 2019 Jun; 60(6):570-577. PubMed ID: 31124341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The special challenge of nonadherence with sublingual immunotherapy.
    Bender BG; Oppenheimer J
    J Allergy Clin Immunol Pract; 2014; 2(2):152-5. PubMed ID: 24607041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of adherence to allergen-specific immunotherapy.
    Senna G; Ridolo E; Calderon M; Lombardi C; Canonica GW; Passalacqua G
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):544-8. PubMed ID: 19823080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of sublingual immunotherapy in children.
    Arasi S; Passalacqua G; Caminiti L; Crisafulli G; Fiamingo C; Pajno GB
    Expert Rev Clin Immunol; 2016; 12(1):49-56. PubMed ID: 26496537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual immunotherapy: the optimism and the issues.
    Pajno GB
    J Allergy Clin Immunol; 2007 Apr; 119(4):796-801. PubMed ID: 17306355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.